Rubella ( IgG) Ab ELISA
Specification:
Catalog Number: Rubella IgG HU-LB23
Description: Rubella IgG ELISA
Sample Type: Serum
Sample Size: 5 µl
Available Sizes: 96 Wells
Incubation: 1hour(s) 30 minutes (s)
Protocol: Rubella IgG ELISA
Regulatory Status: RUO
Product Distribution:Available worldwide

The Life Biological  ELISA, Rubella IgG is intended for use in evaluating a patient's serologic
status to rubella virus infection. It is also used to evaluate paired sera for the presence of a significant increase in specific IgG as indicative of a recent or current rubella virus infection.
Rubella is a herpes virus. Generally rubella is considered a mild adolescence disease. However a maternal infection could be transmitted through the placenta to the fetus, causing congenital rubella. Congenital rubella may result in chronic cardiac disease, growth retardation, hepatosplenomegaly, malformations and other severe anomalies. Children born asymptomatic may develop these abnormalities later in life. To reduce risk of such severe complications, accurate serological methods must be performed to determine the serologic status of childbearing aged women. The presence of rubella specific IgG in the bloodstream attests immunity to rubella. A woman tested to be non-immune can be educated on the availability of vaccination. An increase in rubella IgG denotes an acute infection and differentiates rubella from other exanthematous diseases. Expecting women with current rubella infection should be counseled on the consequences of congenital infection.